TD Asset Management
IMDZ

TD Asset Management’s Immune Design Corp. IMDZ Stock Holding History

TD Asset Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,700
Closed -$275K – 1420
2015
Q4 		$275K Sell
13,700
-19,100
-58% -$329K ﹤0.01% 1252
2015
Q3 		$400K Buy
32,800
+1,500
+5% +$28.1K ﹤0.01% 1128
2015
Q2 		$646K Buy
31,300
+16,900
+117% +$399K ﹤0.01% 1059
2015
Q1 		$304K Hold
14,400
– – ﹤0.01% 1239
2014
Q4 		$443K Hold
14,400
– – ﹤0.01% 1131
2014
Q3 		$254K Buy
+14,400
New +$182K ﹤0.01% 1197

Other funds holding IMDZ

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

TD Asset Management's IMDZ Position: Q1 2016 in Review

TD Asset Management sold out of Immune Design Corp. (IMDZ) in Q1 2016, closing a stake of 13,700 shares — an estimated $275K sold.

TD Asset Management first reported a position in IMDZ in Q3 2014 and held it in 6 quarters. The position peaked at $646K in Q2 2015. 59 funds tracked by Wall St. Rank hold IMDZ as of Q1 2016.

  • TD Asset Management reported no remaining Immune Design Corp. position as of Q1 2016 after selling out during the quarter.
  • TD Asset Management sold 13,700 Immune Design Corp. shares in Q1 2016, an estimated $275K.
  • TD Asset Management first reported a position in Immune Design Corp. in Q3 2014 and held it in 6 quarters.
  • TD Asset Management's Immune Design Corp. position peaked at $646K in Q2 2015.
  • 59 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2016.

Based on TD Asset Management's 13F filing for Q1 2016, filed 5 May 2016.